Latest News and Press Releases
Want to stay updated on the latest news?
-
Intravacc secures $633K funding from CARB-X to develop a vaccine against or Neisseria gonorrhoeae.
Want to stay updated on the latest news?
Intravacc secures $633K funding from CARB-X to develop a vaccine against or Neisseria gonorrhoeae.